Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data.
about
Clinical indications for thrombopoietin and thrombopoietin-receptor agonistsBeyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.Platelet count or bleeding as the outcome in ITP trials?Platelet response as the basis for approval in chronic immune (idiopathic) thrombocytopenic purpura (ITP): a regulatory perspective.Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.
P2860
Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Bleeding and mortality outcome ...... thrombopoietin mimetics data.
@ast
Bleeding and mortality outcome ...... thrombopoietin mimetics data.
@en
type
label
Bleeding and mortality outcome ...... thrombopoietin mimetics data.
@ast
Bleeding and mortality outcome ...... thrombopoietin mimetics data.
@en
prefLabel
Bleeding and mortality outcome ...... thrombopoietin mimetics data.
@ast
Bleeding and mortality outcome ...... thrombopoietin mimetics data.
@en
P2093
P2860
P356
P1476
Bleeding and mortality outcome ...... thrombopoietin mimetics data.
@en
P2093
Ivy Altomare
Jeffrey Wasser
Vinod Pullarkat
P2860
P304
P356
10.1002/AJH.23275
P577
2012-06-22T00:00:00Z